Rl. Tellam et al., Role of oligosaccharides in the immune response of sheep vaccinated with Lucilia cuprina larval glycoprotein, peritrophin-95, INT J PARAS, 31(8), 2001, pp. 798-809
The larvae of the fly Lucilia cuprina cause a cutaneous myiasis in mammalia
n hosts, particularly sheep. The glycoprotein, peritrophin-95, isolated fro
m Lucilia cuprina larval peritrophic matrix, is a candidate vaccine antigen
. This protein induced an immune response in vaccinated sheep that inhibite
d larval growth. Recombinant forms of peritrophin-95 were produced in bacte
ria and baculovirus-infected insect cells. The bacterial protein was not gl
ycosylated and incorrectly folded whereas the insect cell-expressed protein
was glycosylated and probably correctly folded. Sheep immunised with purif
ied native peritrophin-95 generated strong larval growth inhibitory activit
y in their sera, whereas sheep immunised with either recombinant form of pe
ritrophin-95 generated only relatively weak inhibitory activity. Ingested o
vine antibodies to native peritrophin-95 mediated the anti-larval growth ac
tivity and this was independent of the presence of ovine complement. The ac
tivity was associated with IgC(1) and IgG(2) but not IgM. There were strong
antibody responses to both the correctly folded native peritrophin-95 poly
peptide and the oligosaccharides present on this glycoprotein. Immune-affin
ity isolation of antibody to the peritrophin-95 polypeptide and antibody to
peritrophin-95 oligosaccharides demonstrated that the larval growth inhibi
tory activity resided with both antibodies. Lectin blots and ELISA data sho
wed substantial differences between the oligosaccharides attached to native
peritrophin-95 and insect cell-expressed recombinant peritrophin-95. It wa
s concluded that the oligosaccharides attached to native peritrophin-95 and
its unique polypeptide structure are essential for the induction of larval
growth inhibitory activity in the sera of sheep vaccinated with this antig
en. (C) 2001 Australian Society for Parasitology Inc. Published by Elsevier
Science ltd. All rights reserved.